NCT06856967View on ClinicalTrials.gov

Evaluation of the Effect of Nirsevimab on Hospitalizations Due to RSV Infection in Infants Under One Year of Age.

RecruitingOBSERVATIONAL
Enrollment

138

Participants

Timeline

Start Date

December 4, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

April 30, 2025

Conditions
Respiratory Synctial Virus Infections
Interventions
DRUG

Nirsevimab

Evaluation of drug exposure in cases and controls

Trial Locations (8)

50012

RECRUITING

SOC Pediatria Ospedale Santa Maria Annunziata, Bagno a Ripoli

50134

RECRUITING

SOC Neonatologia e Terapia Intensiva Neonatale, Ospedale San Giovanni Di Dio, Florence

50139

RECRUITING

Meyer Children's Hospital IRCCS, Florence

51100

RECRUITING

SOC Pediatria e Neonatologia Ospedale San Jacopo, Pistoia

52100

RECRUITING

SOC Pediatria Ospedale San Donato, Arezzo

53100

RECRUITING

SOC Pediatria AOU Senese, Siena

56123

RECRUITING

Azienda Ospedaliero Universitaria Pisana, Pisa

59100

RECRUITING

SOC Pediatria e Neonatologia Ospedale Santo Stefano, Prato

All Listed Sponsors
lead

Meyer Children's Hospital IRCCS

OTHER